Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : pipeline development

Lakewood-Amedex Appoints Joseph Tucker to Board After Nasdaq Listing

Lakewood-Amedex Appoints Joseph Tucker to Board After Nasdaq Listing
04/28/2026 | Companies
Lakewood-Amedex Biotherapeutics Inc, a clinical-stage biotech firm focused on developing a new category of powerful, rapid-acting, broad-spectrum antimicrobials known as the Bisphosphocin® class, has announced the addition of Joseph Tucker, Ph.D., to its Board of Directors. Dr. Tucker, who...
antibiotic resistance, antimicrobial drugs, biotech leadership, biotechnology, Bisphosphocin, board of directors, capital markets, clinical trials, clinical-stage biotech, corporate governance, diabetic foot ulcers, drug development, Enveric Biosciences, healthcare innovation, Joseph Tucker, Lakewood-Amedex Biotherapeutics, Nasdaq listing, neurological disorders, neuropsychiatric disorders, Nu-3, pipeline development, small-molecule therapeutics, strategic growth

Sobi 2025 Annual & Sustainability Report: Advancing Rare Disease Therapies

Sobi 2025 Annual & Sustainability Report: Advancing Rare Disease Therapies
03/31/2026 | Companies
Swedish Orphan Biovitrum AB has published its 2025 Annual and Sustainability Report, highlighting the company’s achievements in advancing innovative therapies for people living with rare diseases. Sobi continues to prioritize sustainable growth through collaboration and scientific expertise,...
annual report 2025, biopharma, breakthrough medicines, corporate sustainability, CSRD, ESRS, EU Taxonomy, global biopharma, healthcare access, innovative therapies, Nasdaq Stockholm, patient care, pharmaceutical revenue, pipeline development, rare disease treatments, rare diseases, scientific expertise, Sobi, sustainability report 2025, Swedish Orphan Biovitrum, TCFD


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com